DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Gene Could Be New Tool to Help Predict Graves’ Disease Relapse
Patients with Graves’ disease who carry a specific gene show a more than seven-times increased risk of relapse after treatment, suggesting a potentially reliable and important biomarker in management of the disease.
There is a high risk of relapse in Graves’ disease, but there are currently no biomarkers proven to be predictors of relapse; the latter could be essential in disease management decision-making, a coauthor of the research explained.
“The risk of relapse in Graves’ disease is quite high — around 40% to 50% in Europe, and 70% to 80% in the United States,” said Masanobu Yamada, MD, PhD, of the Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan, in a press statement by Thyroid.
“Our finding may give us a tool to find at-risk patients at an earlier stage and more effectively tailor their treatment options,” said Dr Yamada.
Related Content
-
Evidence & EducationGraves’ Disease Following Immune Reconstitution or Immunomodulatory Treatment: Should We Manage it any Differe...Graves' disease and other disorders of t...
-
Evidence & EducationTreatment of Hyperthyroidism With Antithyroid Drugs Corrects Mild Neutropenia in Graves’ DiseaseContext: Neutropenia secondary to antit...
-
People & PlacesChildren’s Hospital Los Angeles Thyroid ClinicThe Division of Endocrinology, Diabetes ...
-
People & PlacesUniversity of Pittsburgh Medical Center – Multidisciplinary Thyroid CenterUniversity of Pittsburgh Medical Center ...
-
Evidence & EducationIncreased Cancer Incidence After Radioiodine Treatment for HyperthyroidismBackground: Concerns remain about risk ...
-
Evidence & EducationPredicting Risk of Recurrent Thyrotoxicosis Following Thionamide Withdrawal in Graves’ DiseaseBackground/Aim: Thionamides are a safe ...
-
Evidence & EducationConversion to Graves’ Disease from Hashimoto Thyroiditis: A Study of 24 patientsObjective: The conversion of Hashimoto'...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.